NDC 69933-0720-06 — amberglow BLEMISH PATCHES SALICYLIC ACID 1

🆔 Identity & classification

FDA NDC (as labeled) 69933-720-06

Product NDC 69933-720

11-digit billing NDC 69933072006

RxCUI 2688025

UNII O414PZ4LPZ

UPC 0810208304714, 0810208304820

Application # M006

SPL Set ID 12054430-25ff-4b72-8f64-822b27abb443

DEA schedule Non-controlled

Marketing category OTC MONOGRAPH DRUG

Marketing status On market

FDA listing status Listed (active directory)

Marketing start 2026-07-27

Route TOPICAL

Dosage form PATCH

Substance SALICYLIC ACID

Why two NDCs? The FDA registers this code as 69933-720-06 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 69933-0720-06. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids

Where does this data come from?

Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerPearl World Inc.

FDA applicationM006 (OTC MONOGRAPH DRUG)

Labeler code69933

First marketedJul 2026

Product typeHuman Otc Drug

Portfolio32 products on file

🔎 All NDCs from Pearl World Inc.

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📖 About the active ingredient: Salicylic Acid MedlinePlus · NLM

General information about the ingredient itself — the description of this specific product follows below.

Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or b...

Read the full MedlinePlus article ↗

🧪 What is this product?

Amberglow Blemish Patches is an over-the-counter topical patch containing salicylic acid, a keratolytic agent commonly used in acne and blemish care products. The patch is applied directly to the skin and delivers salicylic acid, which is typically used to help exfoliate the outer layer of skin and reduce excess oil in pores. This product is marketed under FDA's over-the-counter monograph rules for skin-care actives rather than as an individually reviewed drug application.

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

UNII K679OBS311
Carboxymethylcellulose sodium is a plant-derived thickening agent made from cellulose. In medicines, it acts as a binder to hold ingredients together, a disintegrant to help the tablet break apart, or a thickener in liquids.
UNII 4YS74Q4G4J
A plant extract from Centella asiatica containing natural compounds called triterpenoids. It's used as an active ingredient in some formulations for its purported skin-supporting properties, though it functions as a botanical additive rather than a structural component of the medicine.
UNII 7E6SK9QDT8
Cyclodextrins are ring-shaped sugar molecules derived from starch. They're used in medicines as solubilizers to help poorly dissolving drugs dissolve better, and sometimes as binders or stabilizers.
UNII 3C785871IX
A synthetic oil made from refined petroleum hydrocarbons that has been chemically treated to be stable. It serves as a lubricant and glidant to help the medicine flow smoothly during manufacturing and tablet compression.
UNII 7D1YQ9Y5EZ
Hydrogenated polybutene is a thick, wax-like ingredient made by chemically processing petroleum. It acts as a binder and lubricant, helping hold tablet ingredients together and allowing pills to slide smoothly during manufacturing and packaging.
UNII 255PIF62MS
A synthetic antioxidant compound used to prevent oils and fats in medications from breaking down or becoming rancid during storage. It helps maintain the medicine's stability and shelf life.
UNII 241BN7J12Y
Polyisobutylene is a synthetic rubber polymer used as a glidant and lubricant in tablets and capsules. It helps ingredients flow smoothly during manufacturing and reduces friction between particles.
UNII K7S96QM8DV
A synthetic rubber-like plastic made from linked chains of styrene and isoprene. It's used in medicines as a binder to hold ingredients together and as a film-former to create protective coatings on tablets or capsules.
UNII VIF565UC2G
Tea tree oil is an essential oil extracted from the leaves of the Australian tea tree plant. In medicines, it typically serves as a flavoring agent, fragrance, or antimicrobial component in topical formulations.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesPOLYISOBUTENE, HYDROGENATED POLY(C6-14 OLEFIN), CELLULOSE GUM, HYDROGENATED POLYISOBUTENE, HYDROGENATED STYRENE/ISOPRENE COPOLYMER, MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL, PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE, CYCLODEXTRIN, CENTELLA ASIATICA EXTRACT

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?

Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per each	Per package
Retail pharmacies payNADAC · weekly	Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo	No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

ℹ️

No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.

Try another pack size: 24 patches 24 patches 24 patches 24 patches 24 patches

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
amberglow BLEMISH PATCHES 1 mg/100mgthis 69933-0720-06	Pearl	24 patches	—	—	FDA listed	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

2026

On the market since

Jul 2026

📍

2026

Currently FDA-listed

listed with the FDA

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.

⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.

Period

Total Part D spend

$11.2K

Claims incl. refills

43

Beneficiaries

35

Spend / beneficiary

$319.01

Spend / claim

$259.66

Trend by period

💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for amberglow BLEMISH PATCHES (this brand).

Top reported reactions

Vomiting216

Pruritus205

Weight Decreased188

Condition Aggravated184

Urticaria184

Weight Increased183

Hypertension181

Age at onset

Neonate7

Infant1

Child8

Adolescent5

Adult170

Elderly94

Reporter sex

Male · 37%

Female · 63%

Unknown · 0%

Serious outcomes

Hospitalization623

Death611

Life-threatening174

Disabling124

Reports over time (by year) — tap or hover for the count & year

Most recent year is provisional (FAERS lags ~3 months).

Where does this data come from?

Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDC	Description	Marketing start	Status
69933-0720-02	1 BAG in 1 POUCH (69933-720-02) / 2 PACKAGE in 1 BAG / 12 PATCH in 1 PACKAGE / 40.301 mg in 1 PATCH	2026-07-27	Active
69933-0720-03	1 BAG in 1 POUCH (69933-720-03) / 2 PACKAGE in 1 BAG / 12 PATCH in 1 PACKAGE / 40.301 mg in 1 PATCH	2026-07-27	Active
69933-0720-04	1 BAG in 1 POUCH (69933-720-04) / 2 PACKAGE in 1 BAG / 12 PATCH in 1 PACKAGE / 40.301 mg in 1 PATCH	2026-07-27	Active
69933-0720-06 You're viewing this	1 BAG in 1 POUCH (69933-720-06) / 2 PACKAGE in 1 BAG / 12 PATCH in 1 PACKAGE / 40.301 mg in 1 PATCH	2026-07-27	Active
69933-0720-07	1 BAG in 1 POUCH (69933-720-07) / 2 PACKAGE in 1 BAG / 12 PATCH in 1 PACKAGE / 40.301 mg in 1 PATCH	2026-07-27	Active
69933-0720-08	1 BAG in 1 POUCH (69933-720-08) / 2 PACKAGE in 1 BAG / 12 PATCH in 1 PACKAGE / 40.301 mg in 1 PATCH	2026-07-27	Active

Pack size FAQ

What quantity is in NDC 69933-0720-06?

NDC 69933-0720-06 contains 24 patches — 1 bag in 1 pouch / 2 package in 1 bag / 12 patch in 1 package / 40.301 mg in 1 patch.

What is the difference between NDC 69933-0720-06 and NDC 69933-0720-02?

Both are amberglow BLEMISH PATCHES SALICYLIC ACID 1 mg/100mg Patch — the drug itself is identical. NDC 69933-0720-06 is the 24 patches package, while NDC 69933-0720-02 is the 24 patches package.

What NDC number is used to bill for this package of amberglow BLEMISH PATCHES SALICYLIC ACID 1 mg/100mg Patch?

Bill NDC 69933-0720-06 — the 11-digit billing format is 69933072006. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product

What data is (and isn’t) available for this NDC — tap to expand

NDC identity (package / product / labeler codes)	✓ Available
Labeler	✓ Available
Product & package description	✓ Available
Marketing category & status	✓ Available
Active ingredient / dosage form / route	✓ Available
FDA label (SPL via DailyMed)	✓ Available
Package photos	✓ Available
Inactive ingredients (structured)	✓ Available
NADAC pharmacy acquisition price (CMS)	— Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data	— Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk	— Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)	— Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.

“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?

An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.

Why is there no price listed?

The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.

Is the NDC printed on the package the same as the 11-digit billing NDC?

Yes, they identify this exact package in different formats. The FDA registers it as 69933-720-06, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 69933-0720-06, written without dashes as 69933072006. The Identity section at the top of this page lists every form of this code.

What do the three segments of this NDC mean?

In 69933-0720-06, the first segment (69933) is the labeler code FDA assigned to Pearl World Inc.; the middle segment (0720) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (06) identifies this exact package size and type. Together they name one specific package of one specific product.

Is this package still being marketed?

Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Pearl World Inc.. Listing status can change — the directory data on this page refreshes weekly.

Does this product come in other package sizes?

Yes — the FDA directory lists 5 other package presentations of this same product, including 24 patches (69933-0720-02), 24 patches (69933-0720-03), 24 patches (69933-0720-04). Each has its own NDC and its own page — see the package list near the top of this page.

Who lists this product with the FDA?

Pearl World Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.

Do I need a prescription for this product?

This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.

This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.

Where does this data come from?

Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 6 words ▾

USES FOR THE TREATMENT OF ACNE.

⏱️ Dosage and Administration 44 words ▾

DIRECTIONS ADULTS AND CHILDREN OVER 12 YEARS: • CLEAN AND DRY AFFECTED AREA BEFORE APPLICATION. • APPLY PATCH TO BLEMISH AND PRESS FIRMLY FOR 3-5 SECONDS. • LEAVE PATCH ON FOR UP TO 6-8 HOURS. • REMOVE AND REPLACE WITH NEW PATCH AS NEEDED.

⚠️ Warnings 95 words ▾

WARNINGS FOR EXTERNAL USE ONLY. WHEN USING THIS PRODUCT • USING OTHER TOPICAL ACNE MEDICATIONS AT THE SAME TIME OR IMMEDIATELY FOLLOWING USE OF THIS PRODUCT MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE MEDICATION SHOULD BE USED UNLESS DIRECTED BY A DOCTOR. • AVOID CONTACT WITH EYES.

STOP USE AND ASK A DOCTOR IF • IRRITATION OR REDNESS DEVELOPS AND PERSISTS. DO NOT USE • ON IRRITATED OR SUNBURNT SKIN. KEEP OUT OF REACH OF CHILDREN.

IF INGESTED GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

📦 Storage and Handling 9 words ▾

OTHER INFORMATION • STORE IN A COOL, DRY PLACE.

🧪 Active Ingredient 5 words ▾

ACTIVE INGREDIENT SALICYLIC ACID 1%

🧪 Inactive Ingredients 26 words ▾

INACTIVE INGREDIENTS: POLYISOBUTENE, HYDROGENATED POLY(C6-14 OLEFIN), CELLULOSE GUM, HYDROGENATED POLYISOBUTENE, HYDROGENATED STYRENE/ISOPRENE COPOLYMER, MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL, PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE, CYCLODEXTRIN, CENTELLA ASIATICA EXTRACT

🎯 Purpose 3 words ▾

PURPOSE ACNE TREATMENT

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Salicylic Acid NDCsSame ingredient 🏭 All Pearl labeler NDCsLabeler code 69933 📖 Read the Salicylic Acid drug informationUses, warnings & side effects

amberglow BLEMISH PATCHES SALICYLIC ACID 1 mg/100mg Patch, 24 patches

🆔 Identity & classification

🏷️ RxNorm drug class

🏭 Manufacturer & labeler

🩺 Clinical

Patient education

Supplement & herbal interactions

🧪 Inactive Ingredients / Excipients

Inactive ingredient FAQ

💲 Pricing

🔁 Therapeutic equivalents

⏳ Availability & generic status

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

🔬 Reported adverse events (FAERS)

Top reported reactions

Age at onset

Reporter sex

Serious outcomes

📦 Packaging — all sizes for this product

Pack size FAQ

🧭 About this NDC listing & data coverage

Questions about this listing

📄 FDA label — Drug Facts FDA SPL

🔗 Related NDC lookups